Budget Impact of Adaptive Abiraterone Therapy for Castration-Resistant Prostate Cancer.
Am Health Drug Benefits
; 14(1): 15-20, 2021 Mar.
Article
in En
| MEDLINE
| ID: mdl-33841621
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Health_economic_evaluation
Language:
En
Journal:
Am Health Drug Benefits
Year:
2021
Document type:
Article